Prophylaxis of thromboembolic disease in obstetrics after the French guidelines publication

被引:3
作者
Chauleur, C. [1 ]
Vieira, C. [1 ]
Seffert, P. [1 ]
机构
[1] CHU St Etienne, Hop Nord, Dept Obstet Gynecol, F-42270 St Priest En Jarez, France
来源
GYNECOLOGIE OBSTETRIQUE & FERTILITE | 2008年 / 36卷 / 01期
关键词
thromboembolic disease; risk factor; prevention; pregnancy; cesarean; guidelines;
D O I
10.1016/j.gyobfe.2007.07.043
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objectives. - This work is a study of the prophylaxis of maternal venous thromboembolism (VTE) after the publication of the French guidelines and a comparison between the practice and the guidelines. Population and methods. - Inquiry into the practice of 193 anaesthetists from maternities of the Rhone-Alps area has been made. Results. - Of the 48.2% anaesthetists who answered, 92.5% of them estimate that the caesarean is a risk factor of VTE; 87% prescribe an antithrombotic treatment and 6.5% treat differently the prophylactic caesareans and the urgent ones. The classification of the risk factors is identical to the guidelines for the age, the hypertension and the prophylactic caesarean (p < 0.0001). For all the other factors, the risk is overestimated, leading to an over-treatment. Eighty percent of the anaesthetists read the guidelines and 84% give them a positive value. There is a better adequacy between the guidelines and the professionals from university hospitals as compared to the non university hospitals ones (p = 0.0027). Discussion and conclusions. - Patients are managed approximately and very differently from one consultant to another. A facility of use of the guidelines will undoubtedly make it possible to obtain a more coherent attitude. (C) 2007 Elsevier Masson SAS. Tous droits reserves.
引用
收藏
页码:23 / 34
页数:12
相关论文
共 24 条
[1]  
*ANAES, 2003, C CONS THR GROSS PRE
[2]  
*ANAES, 2005, C CONS REC PRAT CLIN
[3]   Use of antithrombotic agents during pregnancy [J].
Bates, SA ;
Greer, IA ;
Hirsh, J ;
Ginsberg, JS .
CHEST, 2004, 126 (03) :627S-644S
[4]  
BRONNAR J, 1999, AM J OBSTET GYNECOL, V180, P784
[5]  
Carr M H, 1997, J Matern Fetal Med, V6, P264, DOI 10.1002/(SICI)1520-6661(199709/10)6:5<264::AID-MFM4>3.0.CO
[6]  
2-E
[7]  
CHAULEUR C, 2003, J THROMB HAEMOST, pP869
[8]   Risk factors for deep vein thrombosis and pulmonary embolism during pregnancy or post partum: A population-based, case-control study [J].
Danilenko-Dixon, DR ;
Heit, JA ;
Silverstein, MD ;
Yawn, BP ;
Petterson, TM ;
Lohse, CM ;
Melton, LJ .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2001, 184 (02) :104-110
[9]   Antenatal use of enoxaparin for prevention and treatment of thromboembolism in pregnancy [J].
Ellison, J ;
Walker, ID ;
Greer, IA .
BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2000, 107 (09) :1116-1121
[10]   Incidence, clinical characteristics, and timing of objectively diagnosed venous thromboembolism during pregnancy [J].
Gherman, RB ;
Goodwin, TM ;
Leung, B ;
Byrne, JD ;
Hethumumi, R ;
Montoro, M .
OBSTETRICS AND GYNECOLOGY, 1999, 94 (05) :730-734